Journey Medical Corporation DERM Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Journey Medical Corporation in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Journey Medical Corporation's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Journey Medical Corporation's financing cash flow?
- Journey Medical Corporation (DERM) reported financing cash flow of $220K in Q1 2026.
- How has Journey Medical Corporation's financing cash flow changed year-over-year?
- Journey Medical Corporation's financing cash flow decreased by 93.9% year-over-year, from $3.6M to $220K.
- What is the long-term trend for Journey Medical Corporation's financing cash flow?
- Over 3 years (2021 to 2025), Journey Medical Corporation's financing cash flow has grown at a -32.6% compound annual growth rate (CAGR), from $53.02M to $16.23M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.